The Current Ratio as of November 2024 (TTM) for Oxford Nanopore Technologies plc (ONTTF) is 4.45

According to Oxford Nanopore Technologies plc’s latest financial reports and current stock price. The company's current Current Ratio is 4.45. This represents a change of -13.03% compared to the average of 5.12 of the last 4 quarters.

Oxford Nanopore Technologies plc (ONTTF) Historical Current Ratio (quarterly & annually)

How has ONTTF Current Ratio performed in the past?

The mean historical Current Ratio of Oxford Nanopore Technologies plc over the last ten years is 7.72. The current 4.45 Current Ratio has changed 5.67% with respect to the historical average. Over the past ten years (40 quarters), ONTTF's Current Ratio was at its highest in in the March 2022 quarter at 8.51. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Oxford Nanopore Technologies plc (ONTTF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Oxford Nanopore Technologies plc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Oxford Nanopore Technologies plc (ONTTF) Average Current Ratio

How has ONTTF Current Ratio performed in the past?

The current Current Ratio of Oxford Nanopore Technologies plc (ONTTF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Oxford Nanopore Technologies plc (ONTTF) Current Ratio vs. Peers

How is ONTTF’s Current Ratio compared to its peers?

Oxford Nanopore Technologies plc’s Current Ratio is less than AgeX Therapeutics, Inc. (0), greater than Lineage Cell Therapeutics, Inc. (0.64), greater than Cadrenal Therapeutics, Inc. Common Stock (2.48), greater than ImmuCell Corporation (3.69), greater than Reunion Neuroscience Inc. (3.11), greater than Braxia Scientific Corp. (3.52), greater than Algernon Pharmaceuticals Inc. (0.18), greater than Awakn Life Sciences Corp. (0.36), greater than Innovent Biologics, Inc. (0.35), greater than Genscript Biotech Corporation (3.00), less than Nuvalent, Inc. (0), greater than Nurix Therapeutics, Inc. (4.15), less than Seer, Inc. (23.07), less than Quantum-Si incorporated (5.28), less than HCW Biologics Inc. (18.36), less than MediciNova, Inc. (13.42), greater than null (0.07), less than null (16.66),

Build a custom stock screener for Oxford Nanopore Technologies plc (ONTTF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oxford Nanopore Technologies plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Oxford Nanopore Technologies plc (ONTTF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Oxford Nanopore Technologies plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.